Formulation of Sodium Valproate Nanospanlastics as a Promising Approach for Drug Repurposing in the Treatment of Androgenic Alopecia

    September 2020 in “ Pharmaceutics
    Farid A. Badria, Hassan E. Fayed, Amira Mofreh Ibraheem, Ahmed F. State, Eman A. Mazyed
    New to Minoxidil? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study investigated a new formula called SV-loaded nanospanlastics for topical application to treat androgenic alopecia. It showed similar effectiveness to minoxidil lotion but with fewer adverse effects when used to enhance dermal delivery and efficacy of sodium valproate. Our plain-language summary of this paper — not a Tressless recommendation.
    In 2020, a study was conducted to investigate the potential of Sodium Valproate (SV) nanospanlastics for the treatment of Androgenic Alopecia (AGA). The study involved the formulation and optimization of SV-loaded nanospanlastics, which were then characterized using various techniques. The optimized formula (F8) showed a significant improvement in ex vivo permeation compared to free SV. A clinical trial was conducted with 80 patients, divided into two groups. Group A was treated with the optimized SV-loaded nanospanlastic dispersion, while Group B was treated with a marketed 5% minoxidil lotion. The results showed that SV-loaded nanospanlastics were as effective as minoxidil in treating AGA, with fewer side effects. The study concluded that nanospanlastics could be a safe and effective method for improving the topical delivery of SV in the management of AGA.
    Discuss this study in the Community →

    Research cited in this study

    19 / 19 results